Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has reiterated its 'Outperform' rating for Merit Medical Systems (NASDAQ:MMSI) with a maintained price target of $114.
October 18, 2024 | 3:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has reiterated its 'Outperform' rating for Merit Medical Systems with a maintained price target of $114, indicating confidence in the company's performance.
The reaffirmation of the 'Outperform' rating and the maintenance of a $114 price target by Barrington Research suggests a positive outlook for Merit Medical Systems. This could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100